Skip to content

Opening book details…

About this Medicine article

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group by Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann
Publisher
Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 1432-1335)
Published
2018
Language
EN
Field
Medicine (Health Sciences)

More by Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann

Browse all works by Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann